Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Oncology (Williston Park, N.Y.)|January 13, 2000
High-dose therapy with stem-cell transplantation in the malignant lymphomasJ N WinterSeminars in Oncology|November 24, 1999
Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: regulators of growth fraction and programmed cell deathJ N WinterBlood|January 1, 1984
Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal antibodies and cytochemical techniquesJ N Winter, D Variakojis, A L EpsteinThe Journal of Pharmacology and Experimental Therapeutics|November 11, 1992
Kinetic analysis of P-glycoprotein-mediated doxorubicin effluxM S Dordal, J N Winter, A J AtkinsonProgress in Clinical and Biological Research|January 1, 1990
Preclinical evaluation of immunoconjugates consisting of doxorubicin linked to complement-fixing monoclonal antibody DLC-48 for bone marrow purging of B-cell lymphomasJ N Winter, B Bass, T Bringman, et al.Journal of Hematotherapy & Stem Cell Research|February 15, 2001
Ex vivo expansion of early and late megakaryocyte progenitorsP Lefebvre, J N Winter, Y Meng, et al.Annals of Clinical and Laboratory Science|May 1, 1983
Application of monoclonal antibodies to tumor diagnosis and therapyS T Rosen, J N Winter, A L EpsteinBone Marrow Transplantation|February 16, 2000
Typhlitis complicating autologous blood stem cell transplantation for breast cancerL Boggio, R Pooley, S I Roth, et al.Cancer|March 15, 1988
Heterogeneity among the non-Hodgkin's lymphomas. Implications for autologous bone marrow transplantation with in vitro purging using monoclonal antibodiesJ N Winter, R J Marder, B Mankad, et al.Leukemia Research|January 1, 1989
The elimination of malignant B lymphocytes from human bone marrow using monoclonal antibodies DLC-48 and LN-1 and human serum: a preclinical studyJ N Winter, A L Epstein, B Bass, et al.Pageof 6